Screener
Trevi Therapeutics, Inc. TRVI Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Trevi Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
FAQ
- What is Trevi Therapeutics, Inc.'s current ratio?
- Trevi Therapeutics, Inc. (TRVI) reported current ratio of 24.8× in Q1 2026.
- How has Trevi Therapeutics, Inc.'s current ratio changed year-over-year?
- Trevi Therapeutics, Inc.'s current ratio increased by 60.9% year-over-year, from 15.4× to 24.8×.
- What is the long-term trend for Trevi Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s current ratio has grown at a 18.7% compound annual growth rate (CAGR), from 8.3× to 19.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Trevi Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude